Background: Stereotactic body radiotherapy (SBRT) is a well-established treatment option for early stage non-small-cell lung cancer (NSCLC) tumors < 5 cm. There is limited information on tumors > 5 cm.
Patients And Methods: We performed retrospective data collection of patients enrolled onto a prospective SBRT registry study.